ALL RIGHT BIOGRAFER A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  3.3% 2.0% 2.8% 2.4% 2.8%  
Credit score (0-100)  56 69 58 63 53  
Credit rating  BBB A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.2 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -241 -32.5 -32.7 -63.5 -33.8  
EBITDA  -241 -32.5 -32.7 -63.5 -33.8  
EBIT  -723 -536 -502 -1,110 -1,878  
Pre-tax profit (PTP)  2,414.1 360.6 1,464.9 229.7 485.5  
Net earnings  1,882.7 280.1 1,142.7 177.1 170.2  
Pre-tax profit without non-rec. items  2,414 361 1,465 230 485  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 947 775  
Shareholders equity total  2,483 880 1,743 777 770  
Interest-bearing liabilities  1,598 3,450 1,348 5,903 5,454  
Balance sheet total (assets)  4,815 4,653 3,665 7,231 7,113  

Net Debt  972 1,930 1,191 4,740 4,987  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -241 -32.5 -32.7 -63.5 -33.8  
Gross profit growth  -156.7% 86.5% -0.6% -94.3% 46.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,815 4,653 3,665 7,231 7,113  
Balance sheet change%  24.4% -3.4% -21.2% 97.3% -1.6%  
Added value  -241.5 -32.5 -32.7 -640.0 -33.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -482 -503 -470 200 -2,043  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  299.5% 1,647.7% 1,537.1% 1,747.5% 5,549.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  56.5% 8.9% 37.0% 7.1% 17.4%  
ROI %  63.6% 9.6% 39.1% 7.4% 17.4%  
ROE %  78.6% 16.7% 87.1% 14.1% 22.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  51.6% 18.9% 47.5% 10.7% 10.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -402.5% -5,937.5% -3,643.7% -7,464.9% -14,740.1%  
Gearing %  64.4% 392.0% 77.4% 759.6% 708.1%  
Net interest  0 0 0 0 0  
Financing costs %  3.0% 2.5% 3.1% 4.3% 13.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.3 0.8 0.4 0.6 0.6  
Current Ratio  0.3 0.8 0.4 0.6 0.6  
Cash and cash equivalent  626.1 1,520.5 157.4 1,162.7 466.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,498.8 -852.5 -1,094.4 -2,422.4 -2,309.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0